Itopride Pmcs

Itopride Hydrochloride, the active ingredient in Itopride Pmcs, is a prokinetic agent presented as an oral dosage form for oral use. It is used to improve gastrointestinal motility in adults with functional dyspepsia, gastro‑oesophageal reflux disease and gastroparesis.

GNH USA supplies Itopride Pmcs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itopride Hydrochloride acts on gastrointestinal motility disorders to relieve upper‑GI symptoms.

Functional dyspepsia: improves early satiety, post‑prandial fullness and epigastric discomfort. Gastro‑oesophageal reflux disease: reduces reflux episodes and heartburn by enhancing gastric emptying. Gastroparesis: accelerates gastric emptying and alleviates nausea, vomiting and bloating associated with delayed gastric transit.

Adverse reactions may occur with Itopride Hydrochloride use.

Common Side Effects: - Nausea - Diarrhoea - Abdominal pain or discomfort - Headache - Dry mouth - Dizziness

Serious or Rare Side Effects: - Extrapyramidal symptoms such as tremor or rigidity - Severe allergic reactions including rash, angioedema or anaphylaxis - Cardiac arrhythmias - Hepatic dysfunction indicated by elevated liver enzymes - Neutropenia or other blood dyscrasias

Before initiating therapy, consider the following precautions.

Assess renal function: adjust use in patients with severe impairment. Monitor for gastrointestinal symptoms: evaluate efficacy and tolerability. Avoid in patients with known hypersensitivity to itopride or excipients. Use caution in pregnancy: limited safety data are available; weigh benefits against potential risks. Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Itopride Hydrochloride may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Concomitant use with strong dopamine D2 antagonists (e.g., certain antipsychotics) may blunt prokinetic effect. - Combination with other prokinetic agents can lead to excessive cholinergic activity.

Moderate Interactions (Monitor Closely): - Metoclopramide: monitor for additive gastrointestinal effects. - Anticholinergic drugs: may reduce itopride efficacy. - CYP enzyme inhibitors: may increase plasma concentrations of itopride, requiring observation.